Glass House BrandsGLAS 44 Equity-to-Asset is 0.55 as of Mar. 2026, which is 38% above its 10-year median of 0.40. GuruFocus rates GLAS with a GF Score™ of 44/100 and a GF Value™ of $6.46 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Glass House Brands ranks worse than 58.61% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Glass House Brands's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $177.4 Mil. Glass House Brands's Total Assets for the quarter that ended in Mar. 2026 was $325.4 Mil.
Therefore, Glass House Brands's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.55.
The historical rank and industry rank for Glass House Brands's Equity-to-Asset or its related term are showing as below:
GLAS'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.23 Med: 0.4 Max: 0.83
Current: 0.55
During the past 6 years, the highest Equity to Asset Ratio of Glass House Brands was 0.83. The lowest was 0.23. And the median was 0.40.
GLAS's Equity-to-Asset is ranked worse than 58.61% of 1005
companies
in the Drug Manufacturers industry
Industry Median: 0.61
vs GLAS: 0.55
Glass House Brands (NYSE:GLAS) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Glass House Brands Equity-to-Asset Related Terms
Glass House Brands Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Glass House Brands's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Glass House Brands's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glass House Brands Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Glass House Brands's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Glass House Brands's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Glass House Brands's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glass House Brands (GLAS) has a Equity-to-Asset of 0.55 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Glass House Brands and its competitors. This is 38% above median its historical median of 0.40. Over the past decade, Glass House Brands' Equity-to-Asset has ranged from 0.23 to 0.83. According to the industry distribution chart, Glass House Brands ranks #589 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 58.6%.
Is Glass House Brands' Equity-to-Asset too high?
Glass House Brands' current Equity-to-Asset of 0.55 is 38% above median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 0.83. The Drug Manufacturers industry median Equity-to-Asset is 0.61. Glass House Brands' value of 0.55 is 9.8% below this industry median. Based on the distribution chart, Glass House Brands ranks #589 out of 1005 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Glass House Brands has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glass House Brands' Equity-to-Asset compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Glass House Brands ranks #589 out of 1005 companies for Equity-to-Asset. This places Glass House Brands in the lower half of its industry. The industry median Equity-to-Asset is 0.61. Glass House Brands' value of 0.55 is 9.8% below this benchmark. Historically, Glass House Brands' own Equity-to-Asset has ranged from 0.23 to 0.83 over the past decade. While the company's 10-year median is 0.40 vs. the industry median of 0.61, Glass House Brands has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glass House Brands's current Equity-to-Asset of 0.55 is 9.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Glass House Brands and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glass House Brands's current Equity-to-Asset is 0.55, which is 38% above median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glass House Brands stock overvalued right now?
Based on GuruFocus' analysis, Glass House Brands (GLAS) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.46, compared to a current price of $13.00 — trading 101.2% above its estimated fair value. The current Equity-to-Asset is 0.55, which is 38% above median its 10-year median of 0.40 and 9.8% below the Drug Manufacturers industry median of 0.61. Glass House Brands' overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Glass House Brands (GLAS), the current Equity-to-Asset is 0.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Glass House Brands (GLAS) Overvalued in 2026?
Based on GuruFocus' analysis, Glass House Brands stock appears to be overvalued.
The current stock price of $13.00 is trading 101.2% above its estimated GF Value™ of $6.46.
GuruFocus considers Glass House Brands to be Significantly Overvalued.
Key valuation signals for GLAS:
Equity-to-Asset: 0.55 (38% above median its 10-year median of 0.40)
GF Value™: $6.46 vs. price of $13.00 (101.2% above fair value)
Industry Position: 9.8% below the Drug Manufacturers median (#589 of 1005)
No single metric tells the full story. See the GLAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
44GF Score
Get the complete analysis for GLAS
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLAS has been successfully added to your 
